Status:
COMPLETED
Obturator Nerve Block in Total Hip Arthrosplasty
Lead Sponsor:
Clinique Medipole Garonne
Conditions:
Primary Total Hip Arthroplasty
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Interest of obturator nerve block for analgesia in total hip arthroplasty remains controversial. This regional anesthesia procedure could provide post-operative pain relief as obturator nerve is respo...
Detailed Description
The best strategy to provide post-operative analgesia in total hip arthroplasty (THA) remains controversial. Many procedures have been descripted. Recent anatomical studies have reported that obturat...
Eligibility Criteria
Inclusion
- 18 years and older
- Primary THA under general anesthesia
- Consent for participation
- Affiliation to the french social security system
Exclusion
- Revision of hip arthroplasty
- Significant psychiatric disturbances
- Minor patient
- Pregnancy
- Breastfeeding
- Patient is in exclusion period as determined by previous study
- Contraindication to any drug used in the protocol: acetaminophen, ketoprofen, nefopam, oxycodone, propofol, ketamine, Ropivacaine…
- Chronic pain
- Current use oral morphine or equivalents
Key Trial Info
Start Date :
January 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 22 2020
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04085640
Start Date
January 14 2020
End Date
September 22 2020
Last Update
December 14 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Medipole Garonne
Toulouse, France, 31036